|
Ethical and Legal Considerations in Mitigating Pandemic Disease
PAHO Headquarters – Conference Room A 525 23rd Street, NW Washington, D.C. September 19-20, 2006 AGENDATuesday, September 19, 2006
9:00: Welcome and Opening Remarks - Stanley M. Lemon, M.D., Chair, Forum on Microbial Threats
9:15 – 10:00: KEYNOTE ADDRESS: Dr. David Heymann (WHO) "Past as Prologue?"
10:00 – 10:15: Discussion
Session I: Understanding the Challenges of the Future by Examining the Past: Influenza/Smallpox/SARS
Moderator: Ruth Berkelman, M.D., Emory University, Rollins School of Public Health
10:15 – 11:00: Contemplating Pandemics: The Role of Historical Inquiry in Developing Pandemic Mitigation Strategies for the 21st Century - Howard Markel, M.D., University of Michigan
See presentation slides
11:00- 11:45: The Smallpox Eradication Campaign - D.A. Henderson, M.D. Center for Biosecurity, University of Pittsburgh Medical Center
See presentation slides
11:45 – 12:30: Lessons from SARS – David Heymann, M.D., World Health Organization
12:30 – 1:00: Session I Q&A
1:00 – 1:45: LUNCH
Session II: Domestic, Regional and International Preparedness Planning
Moderator: P. Frederick Sparling, M.D., Vice Chair, Forum on Microbial Threats
1:45 – 2:30: US Government Preparedness Plans - Bruce Gellin, M.D., Office of the Secretary, Department of Health and Human Services
See presentation slides
2:30 – 3:15: Regional Planning Efforts – Oscar Mujica, M.D., MPH, PHE, Epidemiologist, Health Surveillance and Disease Management, Communicable Diseases Unit, Pan American Health Organization
See presentation slides
3:15 – 3:45: Q & A
3:45 – 4:00 BREAK
4:00 – 4:45: Ethical Considerations in International Preparedness Planning Efforts – Alexander Capron, University of Southern California
See presentation slides
4:45 – 5:15: Open Discussion of Session II
5:15– 6:00: Open Discussion of Day 1
6:00 p.m.: ADJOURN
WEDNESDAY, SEPTEMBER 20th, 2006
8:30: Opening Remarks / Summary of Day 1: Margaret A. Hamburg, M.D., Vice Chair, Forum on Microbial Threats
Session III: Disease Mitigation Strategies –Quarantine, Containment & Modeling
Moderator: Gary Roselle, M.D., Program Director for Infectious Diseases, Department of Veterans Affairs Central Office
8:45 – 9:30: Martin Cetron, M.D., Centers for Disease Control and Prevention
See presentation slides
9:30 – 10:15: Lawrence Gostin, J.D., Georgetown University School of Law
10:15 – 10:30: Discussion
10:30 – 11:15: The role of Modeling in Infectious Disease Mitigation and Containment, Joshua Epstein, Ph.D., The Brookings Institution
See presentation slides
11:15 – 11:45: Discussion Panel:
Timothy C. Germann, Ph.D., Los Alamos National Laboratory Jim LeDuc, M.D., Centers for Disease Control and Prevention Victoria Sutton, J.D., Ph.D., Texas Tech University School of Law See presentation slides
Session IV: Ethical Issues in Pandemic Planning and Response
2:15 – 3:00: Ruth Faden, Ph.D., Berman Bioethics Institute, Johns Hopkins University
3:00 – 3:45: Discussion Panel:
Steven Bice, Battelle, Atlanta, Georgia DA Henderson, M.D., Center for Biosecurity, University of Pittsburgh Medical Center Shelley Hearne, DrPH, Johns Hopkins University See presentation slides
3:45 – 4:30: Open Discussion4:30 – 4:45: Closing Remarks/Adjourn
|